These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 21769761

  • 1. [The chronological process of erectile function after low-dose rate prostate brachytherapy for localised prostate cancer].
    Bannowsky A, Bäurle L, Ataniyasov R, Ahlen Hv, Loch T.
    Aktuelle Urol; 2011 Jul; 42(4):252-5. PubMed ID: 21769761
    [Abstract] [Full Text] [Related]

  • 2. The effect on erectile function of 103palladium implantation for localized prostate cancer.
    Ponholzer A, Oismüller R, Somay C, Büchler F, Maier U, Hawliczek R, Rauchenwald M, Madersbacher S.
    BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796
    [Abstract] [Full Text] [Related]

  • 3. Erectile function after brachytherapy with external beam radiation for prostate cancer.
    Fujioka H, Ishimura T, Sakai Y, Fujii T, Jo Y, Takenaka A, Fujisawa M.
    Arch Androl; 2004 Apr; 50(4):295-301. PubMed ID: 15277008
    [Abstract] [Full Text] [Related]

  • 4. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
    Brown MW, Brooks JP, Albert PS, Poggi MM.
    Prostate Cancer Prostatic Dis; 2007 Apr; 10(2):189-93. PubMed ID: 17189954
    [Abstract] [Full Text] [Related]

  • 5. Erectile function after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):437-47. PubMed ID: 15890585
    [Abstract] [Full Text] [Related]

  • 6. Erectile function durability following permanent prostate brachytherapy.
    Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Anderson R, Lief JH.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):639-48. PubMed ID: 19303721
    [Abstract] [Full Text] [Related]

  • 7. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.
    Shemtov OM, Radomski SB, Crook J.
    Can J Urol; 2004 Dec 01; 11(6):2450-5. PubMed ID: 15636671
    [Abstract] [Full Text] [Related]

  • 8. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.
    Morton GC, Loblaw DA, Sankreacha R, Deabreu A, Zhang L, Mamedov A, Cheung P, Keller B, Danjoux C, Szumacher E, Thomas G.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):811-7. PubMed ID: 19836166
    [Abstract] [Full Text] [Related]

  • 9. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C, Ghilezan M, Hollander M, Gustafson G, Korman H, Gonzalez J, Martinez A.
    J Urol; 2005 Sep 01; 174(3):882-7. PubMed ID: 16093980
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.
    Ohebshalom M, Parker M, Guhring P, Mulhall JP.
    J Urol; 2005 Jul 01; 174(1):258-62; discussion 262. PubMed ID: 15947650
    [Abstract] [Full Text] [Related]

  • 11. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S, Cesaretti J, Stone NN, Stock RG.
    BJU Int; 2006 Nov 01; 98(5):979-81. PubMed ID: 17034599
    [Abstract] [Full Text] [Related]

  • 12. Erectile function after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):893-902. PubMed ID: 11958881
    [Abstract] [Full Text] [Related]

  • 13. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan V, Morris WJ.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):155-63. PubMed ID: 16111584
    [Abstract] [Full Text] [Related]

  • 14. The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer.
    Stember DS, Mulhall JP.
    Brachytherapy; 2012 Sep 01; 11(2):87-96. PubMed ID: 22330103
    [Abstract] [Full Text] [Related]

  • 15. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Wust P, von Borczyskowski DW, Henkel T, Rosner C, Graf R, Tilly W, Budach V, Felix R, Kahmann F.
    Radiother Oncol; 2004 Oct 01; 73(1):39-48. PubMed ID: 15465144
    [Abstract] [Full Text] [Related]

  • 16. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancer.
    Gómez-Iturriaga Piña A, Crook J, Borg J, Lockwood G, Fleshner N.
    Urology; 2010 Jun 01; 75(6):1412-6. PubMed ID: 20035986
    [Abstract] [Full Text] [Related]

  • 17. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results.
    Duchesne GM, Williams SG, Das R, Tai KH.
    Radiother Oncol; 2007 Aug 01; 84(2):128-34. PubMed ID: 17561293
    [Abstract] [Full Text] [Related]

  • 18. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS.
    J Urol; 2004 Mar 01; 171(3):1098-104. PubMed ID: 14767279
    [Abstract] [Full Text] [Related]

  • 19. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up.
    Cesaretti JA, Kao J, Stone NN, Stock RG.
    BJU Int; 2007 Aug 01; 100(2):362-7. PubMed ID: 17617140
    [Abstract] [Full Text] [Related]

  • 20. Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial.
    Wiegner EA, King CR.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):442-8. PubMed ID: 20137864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.